We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Half a million women in England have accessed cheaper HRT - the main treatment for negative menopause symptoms - since last April.
Information and resources for leaders, managers and practitioners seeking to improve children’s outcomes by supporting the parental relationship.
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Principles to support decision making for those involved in safely planning and protecting visiting during outbreaks of infectious illness in adult social care.
Actions that local areas can take to reduce health inequalities experienced by people living with mental illness.
Evaluation of the Reducing Parental Conflict programme (RPC) from phase one, 2018 to 2022.
Information, data, guidance and resources about the NCSP.
Randomised controlled trial
Pandemic flu planning information for England and the devolved administrations, including guidance for organisations and businesses.
Information and resources to support commissioners, service providers and others to reduce harm and prevent deaths related to substance misuse.
Population screening programmes can cause harms as well as benefits, which need to be weighed up by the UK National Screening Committee (UK NSC).
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Information from the National Health Service on conditions, treatments, local services and healthy living
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).